from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1318c/-

LFCtreatmentdescriptionclass of inhibitor

-1.048

Amikacinug/mL Amikacintranslation

-1.111

Cap5-10ug/mL Capreomycintranslation

-0.158

Rox10-50 ug/mL Roxithromycintranslation

-0.446

SM2-5 ug/mL Streptomycintranslation

-1.894

Tet5-10 ug/mL Tetracyclinetranslation

0.345

Rif0.2-5ug/mL Rifampicintranscription

0.467

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.441

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.397

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.216

CPZ10-50 ug/mL Chlorpromazinerespiration

1.125

Clofazimine10-13 ug/mL Clofaziminerespiration

0.725

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.995

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.497

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.696

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.171

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.675

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.752

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.099

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.242

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.705

KCN5-20 ug/mL Potassium cyaniderespiration

1.302

NaN30.2-2 mM Sodium aziderespiration

-0.341

Nigericin50 uM Nigericinrespiration

-0.023

TRC10-150 ug/mL Triclosanrespiration

0.105

TRZ10-25 ug/mL Thioridazinerespiration

-0.593

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.035

menadione6-10 ug/mL Menadionerespiration

0.104

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.357

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.544

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.623

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.563

NRP_1Non-replicating persistence stage 1dosRassociated

-0.051

Amp0.2mg/mL AmpicillincellWall

-0.206

Cephalexin20-100 ug/mL CephalexincellWall

-0.225

Cerulenin0.32-5 ug/mL CerulenincellWall

0.260

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.239

EMB10-20 ug/mL EthambutolcellWall

-0.193

Eta12-40 ug/mL EthionamidecellWall

-0.098

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.302

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.174

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.388

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.617

BZA0.12 mg/mL BenzamidearomaticAmides

-0.052

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.426

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.143

H2O24 mM hydrogen peroxideDNAdamaging

-0.086

Levo10 ug/mL LevofloxacinDNAdamaging

0.626

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.750

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.162

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.274

UVUV-irradiationDNAdamaging

-1.442

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.053

Antimycin12.5-50 ug/mL Antimycin A?

0.070

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.358

PA_110-50 ug/mL Antitubercular compound PA-1?

0.187

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.554

PA8240.2-2 ug/mL PA-824?

-0.686

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.027

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.004

Verapamil50 uM Verapamil?

0.082

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.377

methoxatin10-20 ug/mL Methoxatin?